|
 |
Departments
Observations
A message from the editor of FDA Consumer.
Letters to the Editor
Topics: Poison ivy and English ivy.
Updates
The latest information on FDA-related issues, gathered from
FDA Press Releases, Talk Papers, and other sources.
Research Notebook
Reports from public health and medical research.
fda.gov
Places of interest on FDA's Website and other government
and health-related sites.
Investigators' Reports
Selected cases illustrating regulatory and administrative
actions--such as inspections, recalls, seizures, and court
proceedings--by FDA's regional and district offices across
the country.
The Last Word
Commentary: The 'Hidden' Victims of Alzheimer's disease.
|
|
|
|
Features
Joint FDA, NCI
Program to Streamline Drug Development
The National Cancer Institute has joined with the FDA to benefit the more than 1 million Americans diagnosed with cancer each year.
FDA's Response to Food, Dietary
Supplement, and Cosmetic Adverse Events
The FDA is encouraging consumers to report problems with food and cosmetic products as part of an agency-wide initiative.
SARS: Protecting Against a Deadly
Disease
Federal agencies are working to prevent the spread of an emerging infectious disease threat.
Cover Story
Alzheimer's: Searching for a Cure
Researchers hold out hope for preventing and treating this devastating disease.
Hispanic Health: Renewed Collaboration
The FDA renews its commitment to help Hispanic consumers achieve good health.
FDA Works to
Reduce Preventable Medical Device Injuries
More than 100,000 reports of preventable adverse health events involving medical devices come to the FDA each year. Reducing that number is a top priority for FDA Commissioner Mark B. McClellan.
FDA, Red Cross Reach Agreement
to Improve Blood Safety
The American Red Cross signs a consent decree with the FDA to improve its blood storage practices and record keeping.
Speedy Approvals for New Cancer
Treatments
The FDA approves drugs for lung cancer and bone marrow cancer.
|
|
|
FDA Consumer is the official magazine of the U.S. Food and Drug Administration.
Text in the articles in FDA Consumer may
be republished without permission. Credit to FDA Consumer
as the source is appreciated.
|
|
|
